Editas Medicine, Inc.

US$2.57As of Sun 8 Nov 2026, 12:00 UTC
NASDAQ:EDITHealthcare
Country USA
PE (Fwd) •••
TSR 10Y CAGR (15.65%)
Div yield —
ROE (118.82%)
Biotechnology
Beta (5Y) 2.08
PE TTM —
TSR TTM (16.56%)
Mkt cap US$394.7M
ROIC (64.75%)
SE Grade™
Value
Quality
Moat
Consensus
Reference
$2.46
(4.32%)
(77.76%)
Buy 10|2|1|4|1
4Q25
1Q26
2Q26
3Q26
Earnings per share$
0.06
0.06
0.06
0.06
26.38%
11.22%
11.88%
2.39%
Revenue$M
21.44
22.39
22.42
22.17
12.73%
19.03%
15.44%
9.08%
Peers (US$394.7M)
Cap (US$)
PE
394.0M
—
Capital
TTM
5Y
10Y
Leveragex
1.025
(0.023)
(0.017)
EBIT/Intx
2.054
0.112
0.128
Own earn%
(1011.36)
(63.28)
(54.36)
Sh yield%
12.87
50.76
47.45
Owners
Insiders/Inst%
7.94
43.69
Short interest%
4.98
SBC / revenue%
3.66
Record
10Y
Profitable years
10/10
Revenue growth years
10/10
EPS growth years
10/10
Dividend streakyrs
17
Op margin range%
7–15
$1 testx
—
Incr. ROIC%
−21